| For: | Xia RJ, Du XY, Shen LW, Ma JG, Xu SM, Fan RF, Qin JW, Yan L. Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer. World J Gastrointest Oncol 2024; 16(9): 3820-3831 [PMID: 39350980 DOI: 10.4251/wjgo.v16.i9.3820] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i9/3820.htm |
| Number | Citing Articles |
| 1 |
Yibo He, Qianran Hong, Shiliang Chen, Jiayi Zhou, Shengliang Qiu. Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1558091
|
| 2 |
Zhen Yuan, Jing-Hang Wang, Hao Cui, Shu-Yuan Wang, Bo Wei, Jian-Xin Cui. Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots. World Journal of Gastrointestinal Oncology 2025; 17(3): 100997 doi: 10.4251/wjgo.v17.i3.100997
Abstract(402) |
Core Tip(387) |
Full Article(HTML)(1600)
|
Full Article (PDF)-23419K(184)
|
Full Article with Cover (PDF)-23699K(166)
|
Full Article (XML)-291K(112)
|
Audio-1802K(12)
|
Peer-Review Report-239K(97)
|
Answering Reviewers-90K(92)
|
Supplementary Material-585K(102)
|
Times Cited (0)
|
Total Visits (2765)
|
Open
|
| 3 |
Lu Yang, Di Zhou, Ke Cao, Dan Mao, Chenxi Wang, Tao Wei, Yu Deng, Zihan Yi, Wenhui Li, Zhengting Chen. Chemoresistance in the era of immunotherapy: challenges and novel combinatorial strategies for digestive system tumors. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1800910
|